In Chile and around the world, DIPG has no cure.
But it does have names, families, dreams… and hope.
DIPG (diffuse intermediate-brain glioma) is an extremely aggressive type of brain cancer that primarily affects children. Its diagnosis is devastating: there is no treatment in our country. There are no protocols, no access to clinical trials, no options.
But there are families fighting, searching for answers beyond our borders. People traveling against the clock, who need resources, guidance, companionship, and a support network.
At the Santino Pizarro Carrizo Foundation, we are here to accompany, guide, and fund this journey, connecting those facing DIPG in Chile with the most advanced options worldwide.
Childhood cancer cannot wait.
Help us raise awareness. Help us take action.
In the fight against DIPG
We will finance the first few months of relocation and settling in countries like Spain or the USA, covering key expenses while facilitating access to clinical trials and international support networks.
With you from the very beginning
We support families throughout the entire process, offering personalized guidance from diagnosis to specialized treatments.

💜 All for Mailen
Mailen is a little girl of only 2 years old (she turned 2 on June 4th), who faces an extremely delicate health condition.

Four-year-old Carlitos was diagnosed with DIPG brain tumor. We need 150 million [currency unspecified]. Every donation, every prayer counts ❤️✨🙏

We are Martina’s family and we need your help to start raising funds to travel abroad 💗#DIPG

United for a cause 💛 United for Zoe. A little princess, just 4 years old, from Ecuador 🇪🇨, is facing a tough battle today. #DIPG
Honoring Children 🧡
In memory of all the children who inspire our cause. Their stories drive us to work for more research, more support, and more hope for the families facing DIPG today. Their legacy lives on in every step we take.
What is DIPG?
Diffuse Inflammatory Brainstem Glioma (DIPG) is an aggressive brain tumor that primarily affects children between the ages of 5 and 10. It is located in the brainstem, a critical region that controls vital functions such as breathing and movement.
This type of cancer is difficult to treat due to its infiltration of sensitive brain tissue, which limits surgical options. Although radiation therapy is the standard treatment, current research is exploring innovative therapies such as immunotherapy and oncolytic viruses.
If you would like to learn more, you can listen to the presentation by Dr. Guillermo D. Angulo from Nicklaus Children’s Hospital.
Fighting Childhood DIPG/DMG Cancer
At the SPC Foundation, we work every day to provide hope and support to children with DIPG and their families. You too can be part of this cause and help us make a difference.
Donation
For just $12.000 clp, you can be an active part of the change. Your sustained donation powers support programs, innovative treatments, and direct aid to those who need it most.
Solidarity Marketplace
Find products with a purpose, works by partner artists and participate in our charity auction.
Companies
If you have a formally registered business, you can access tax benefits when making donations under Law 21.440.
Our Goal
At the SPC Foundation, we work every day to provide hope and support to children with DIPG and their families. You too can be part of this cause and help us make a difference.
You’re an Artist?
Put your talent to work for a meaningful cause.
Solidarity Marketplace
Join our Charity Marketplace and help families fighting childhood cancer.
Join us
Your art—whether illustration, music, painting, dance, or words—can make visible what others keep silent.
Supporting Foundations
At the Santino Pizarro Foundation, we believe in the power of partnerships. That’s why we collaborate with international foundations that share our commitment to fighting PGID, strengthening support for families, raising awareness, and advancing research.
Foundations in the USA
Foundations in Spain
Together, we join forces for a cause that unites us: to give hope where it is most needed.







